Diagnosed prevalent cases of HER2- breast cancer across 8MM set to reach 4.12 mn in 2034
GlobalData’s latest report, reveals that the increase is partly attributed to higher survival rates of HER2- breast cancer…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cancer
Three CAR-T therapies forecasted to capture over 70 per cent of T-Cell immunotherapy market in 2025
GlobalData’s latest report reveals that the TCI space is entering a new growth phase, driven by clinical success and investor…
Scientists at Newcastle University create a bioprinting method to speed up drug discovery
Newcastle University developed new 3D bio-printer that produces human-like tissue, which holds the potential to speed up the…
Mankind Pharma and Innovent Biologics partner to license and commercialise Sintilimab
Sintilimab, marketed as TYVY (sintilimab injection) in China, is a high-quality PD-1 immunoglobulin G4 monoclonal antibody…
RCC diagnosed incident cases to reach 230,000 in 8MM by 2033: GlobalData
According to GlobalData epidemiologists, there were 19.90 per cent of stage III diagnosed incident cases of RCC and 17.90 per cent…
Miltenyi Biotec and Translational Health Science Institute collaborate to strengthen R&D in…
The collaboration aim to address the growing need for innovative treatments in the fight against cancer by developing innovative…
AstraZeneca’s Tagrisso with chemo approved in China as 1st-line treatment
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy reduced the risk of disease progression or death by…
Scientists investigate if prostate drug could also treat breast cancer that’s spread to the bone
When breast cancer cells spread to other parts of the body it is called secondary or metastatic breast cancer and although…
Our collaborations with Govt of India focus on building resilient healthcare systems
Sylvia Varela, AVP Asia Area, AstraZeneca discusses about the company’s plans to drive market growth, address public health…
Bayer says it makes progress in settlement talks over weedkiller
The drugs and pesticides group is keen to draw a line under the legal dispute, which it inherited via its $63 billion takeover of…